Form 4 for BVS Bioventus Inc.
Accepted 2025-06-10 00:00:00 ET · period of report 2025-06-06 · accession 0001578563-25-000316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-10 | 2025-06-06 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | +7,575 | 79.6K | +11% | $0 |
| D | 2025-06-10 | 2025-06-06 | BVS | Bartholdson John A. | Dir, 10% | M - OptEx | $0.00 | -7,575 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-06-06 | M | A | 7,575 | $0.00 | 79,620 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-06-06 | M | D | 7,575 | $0.00 | 0 | D | — · — to — | 7,575 Class A Common Stock | (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. (F4) The RSUs vested on June 6, 2025. |